Kembali ke Daftar Obat

Panduan penyiapan dan pemberian terapi medikasi
Furosemide

Risiko Phlebitis rendah

Kejadian Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar

Penyiapan

Sediaan

  • 10 mg/mL

Rekomendasi Pengenceran (Konsentrasi)

tidak diencerkan

Pelarut

Pemberian

Rekomendasi Akses

IV

Rekomendasi Durasi Pemberian

1-2 menit (IV IM bolus)
4 mg/menit (titrasi)

Stabilitas Obat Setelah Rekonstruksi

Keamanan

pH

8,0-9,3
pH risiko sedang (4,0-5,0 / 7,5-9,0)

Osmolaritas Sebelum Pengenceran

287-291
Osmolaritas rendah (<600)

Phlebitis

Ya
Jarang/Berpotensi (>1/1000 kejadian)
Tetap waspada, gunakan dengan prosedur standar

Inkompatibilitas

  • Amiodarone HCl
  • Chlorpromazine HCl
  • Conivaptan HCl
  • Diazepam
  • Dobutamine HCl
  • Doxapram HCl
  • Eptifibatide
  • Gentamicin Sulfate
  • Hydrocortisone Sodium Succinate
  • Isoproterenol HCl
  • Meperidine HCl
  • Metoclopramide HCl
  • Prochlorperazine Promethazine HCl
  • Caffeine Citrate
  • Dimenhydrinate
  • Doxapram HCl
  • Doxorubicin HCl
  • Droperidol
  • Milrinone Lactate
  • Pantoprazole Sodium
  • Vincristine Sulfate
  • Amsacrine
  • Azithromycin
  • Blinatumomab
  • Caspofungin Acetate
  • Chlorpromazine HCl
  • Ciprofloxacin
  • Cisatracurium Besylate
  • Clarithromycin
  • Diltiazem HCl
  • Dobutamine HCl
  • Dopamine HCl
  • Doxorubicin HCl
  • Droperidol
  • Eravacycline Dihydrochloride
  • Esmolol HCl
  • Famotidine
  • Fenoldopam Mesylate
  • Filgrastim
  • Fluconazole
  • Gemcitabine HCl
  • Hydralazine HCl
  • Idarubicin HCl
  • Isavuconazonium Sulfate
  • Labetalol HCl
  • Levofloxacin
  • Meperidine HCl
  • Metoclopramide HCl
  • Midazolam HCl
  • Milrinone Lactate
  • Morphine sulfate
  • Nesiritide
  • Nicardipine HCl
  • Nitroglycerin
  • Ondansetron HCl
  • Oritavancin diphosphate
  • Phenylephrine HCl
  • Vasopressin
  • Vancomycin HCl
  • Vecuronium Bromide
  • Vincristine Sulfate
  • Vinorelbine Tartrate
  • Vinblastine Sulfate

Klasifikasi GHS

Irritant
Health Hazard

Manifestasi GHS

H315 (11.7%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (11.2%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (11.7%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
H351 (13.8%): Suspected of causing cancer [Warning Carcinogenicity]
H360 (78.8%): May damage fertility or the unborn child [Danger Reproductive toxicity]
H361 (14.2%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

Sumber

  • https://pubchem.ncbi.nlm.nih.gov/compound/3440
  • American Society of Health-System Pharmacists. 2021. ASHP® Injectable Drug Information: A Comprehensive Guide to Compatibility and Stability. 2021 Edition. eBook. American Society of Health-System Pharmacists. ISBN: 978-1-58528-690-4. doi.org/10.37573/9781585286850